Effect of tesaglitazar, a dual PPAR alpha/gamma agonist, on glucose and lipid abnormalities in patients with type 2 diabetes: a 12-week dose-ranging trial
(Q51483374)
scientific article published in December 2006
scientific article published in December 2006
Language:
Current Data About
Effect of tesaglitazar, a dual PPAR alpha/gamma agonist, on glucose and lipid abnormalities in patients with type 2 diabetes: a 12-week dose-ranging trial
other details
| description | scientific article published in December 2006 |
External Links
| (P356) |
10.1185/030079906X154169
|
| (P698) |
17166340
|